Mobile

Safety of the Inactivated, Split-Virion Influenza Vaccine Administered by the Intradermal Route in Healthy Children

Update Il y a 4 ans
Reference: EUCTR2005-002965-35

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To describe the safety of the 9µg formulation of the inactivated, split-virion influenza vaccine administered by the intradermal (ID) route in children aged 6 to 35 months and 3 to 8 years.

Inclusion criteria

  • Vaccination of healthy children aged 6 to 35 months and 3 to 8 years (2 doses at a 28 day-interval)

Links